The COVID-19 pandemic may be over, but our immune systems are still feeling the impact. After years of battling constant viral threats, from COVID-19 to seasonal flu and other infections, our body’s defense system is exhausted. Many people continue to experience lingering inflammation, frequent illnesses, and slower recovery times. This extended state of immune stress has compromised us further to chronic illness, including autoimmune diseases and even neurodegenerative diseases such as Parkinson's. So why is our immune system still in trouble? And how do we give it its power back? Understanding immune exhaustion is the beginning of rebuilding our body's natural immunity.
A weakened immune system makes people more susceptible to disease, mental illnesses, and even sleep disorders. Now, new research indicates that immune system depletion may play an important role in the onset of Parkinson's disease, a degenerative neurologic disorder that compromises movement and cognition.
Dysfunctional immune response is a leading cause of long-standing inflammation within the body, that has been found to contribute towards a multitude of conditions, including cardiovascular conditions, diabetes, depression, and neurodegenerative diseases such as Alzheimer's.
As people age, their immune system naturally becomes less effective. This deterioration, referred to as immune exhaustion, may be a key contributor to the onset and progression of Parkinson’s disease. Rebecca Wallings, a Parkinson’s Foundation Launch Award grant recipient and senior postdoctoral fellow at the University of Florida, believes that an accumulation of exhausted immune cells could be driving neurodegeneration in Parkinson’s patients.
Parkinson's disease is most commonly linked with the degeneration and loss of dopaminergic neurons—motor nerve cells that produce dopamine, an essential neurotransmitter for movement. While researchers have long suspected inflammation is involved in this neurodegeneration, the mechanisms are not yet well understood.
Wallings' study is on immune cell exhaustion, a process by which aging immune cells fail to control immune responses effectively. Her research indicates that instead of dampening inflammation in Parkinson's patients, attempts should be made to rejuvenate the immune system to regain its functionality.
One of the major findings of Wallings' work is the function of mitochondrial impairment in immune cell exhaustion. Mitochondria are commonly called the powerhouses of cells, as they are vital for generating energy. As mitochondria age and become inefficient, immune cells fail to function well, potentially accelerating neurodegeneration in Parkinson's disease.
Wallings has found that mutations in the LRRK2 gene, a recognized genetic risk factor for Parkinson's disease, are linked with defective mitochondrial function and immune cell exhaustion. Her current work includes testing various therapeutic approaches to restore mitochondrial function in immune cells with the potential to enhance the immune system and potentially prevent or treat Parkinson's disease.
For decades, the standard practice in treating Parkinson's has been to suppress brain inflammation. Yet Wallings' work indicates that instead of slowing down immune responses, restoring the immune system could be a more successful strategy. By addressing mitochondrial impairment and immune resilience, researchers can potentially reverse or slow down Parkinson's disease.
Wallings is now looking into how to rejuvenate immune cells by fixing mitochondria. She studies immune cells from patients with Parkinson's as well as from healthy subjects and performs experiments on animal models to determine if rejuvenation of the immune system could result in improved disease outcomes.
While there is no cure for Parkinson's disease, some lifestyle adjustments may decrease the chances of developing the illness. Since neurodegenerative diseases are associated with chronic inflammation and immune dysfunction, developing habits that enhance immune function might prove helpful.
Diet: There is evidence to suggest that eating in accordance with the Mediterranean or MIND diets, both high in antioxidants, healthy fats, and anti-inflammatory foods, can encourage brain wellness and reduce Parkinson's risk.
Avoiding Dangerous Substances: Restricting alcohol and nicotine use can maintain a robust immune system and suppress inflammation.
Reducing Stress: Chronic stress weakens immune function, so methods such as meditation, exercise, and sufficient sleep can lead to improved overall well-being.
Recently weight loss medication has gained a lot of popularity. Many people are getting these medicines prescribed in order to lose weight; however, it is not as straightforward of a process as we think it is. There are various aspects of it you should know about before you start taking the medication. One of which is that one needs to take it consistently even after they lose weight because they may gain weight back. How effective the medicine is on you also matters.
Whenever it comes to new medication that can majorly alter a person’s lifestyle physique as well as how their body functions, like Ozempic, one has to be very careful with the doses.
While too much of it can trigger health issues, less of it may not give you the desired effect. So, what should a person do when they are not seeing the results they want? A new study shows that a higher dosage than what we currently have approved, could actually help with better weight loss in obese adults.
An international study has found that a higher weekly dose of the drug semaglutide (7.2 mg) is safe and more effective for weight loss than the currently approved dose (2.4 mg). The findings, published in The Lancet Diabetes & Endocrinology, suggest that this higher dose could be a new and powerful option for adults living with obesity, including those who also have type 2 diabetes.
In adults who do not have diabetes, a 7.2 mg weekly dose of semaglutide led to a significant average weight loss of almost 19%. This is a notable improvement over the 16% weight loss seen with the standard 2.4 mg dose and a 4% loss in the placebo group (who received a dummy treatment).
Almost half of the participants on the higher dose lost 20% or more of their body weight, with about one-third losing at least 25%. These participants also saw improvements in their waist circumference, blood pressure, blood sugar, and cholesterol levels, which are all important for reducing health risks related to obesity.
For adults with obesity and type 2 diabetes, the 7.2 mg dose also showed better results. These individuals experienced an average weight loss of 13%, compared to 10% with the 2.4 mg dose and 3.9% with the placebo. The higher dose also led to significant reductions in blood sugar levels and waist size.
The study found that the higher dose of semaglutide was safe and well-tolerated overall. The most common side effects were gastrointestinal issues, like nausea and diarrhea, and some tingling sensations. However, most of these side effects were manageable, resolved on their own over time, and did not cause people to drop out of the trial. The researchers did not find any increase in serious health problems or severe drops in blood sugar (hypoglycemia) with the higher dose.
Researchers believe this higher dose could help more people achieve their health goals and reduce the worldwide burden of obesity. They also noted that more research is needed to fully understand the long-term benefits and risks.
Credits: Canva
Lymphoma is a form of blood cancer that starts in the lymphatic system, an essential part of the body’s immune defense. It develops when lymphocytes, a type of white blood cell, begin to grow and multiply in an abnormal way. The condition is broadly classified into two types, Hodgkin lymphoma and non-Hodgkin lymphoma, each with its own features and treatment methods, as per the American Oncology Institute. With cases becoming increasingly common, here are some of the early warning signs of lymphoma you should be aware of.
According to Netmeds, the theme for World Lymphoma Awareness Day 2025 is ‘Honest Talk.’ This year’s message highlights the need for open and transparent conversations between patients, caregivers, families, and healthcare professionals.
ALSO READ: Parkinson’s Mystery Cracked? Study Finds Brain Cells May Be Burning Themselves Out
Spotting these signs early gives you the chance to seek medical help before lymphoma advances, when treatment is most effective. If you notice any of these symptoms lasting longer than two weeks, make an appointment with your doctor. An early check-up will ensure you get the right evaluation and tests without any delay.
(Credit- Canva)
Although as kids many of us enjoyed the perfect vision, it isn’t uncommon to find that you may need glasses as things start looking blurry. Weak eyesight can be caused due to a lot of reasons, whether it is strained usage of our eyesight like using improperly lit spaces to read, using electronics at night, or simply aging.
The simple science behind wear eyesight is when the muscles that aid our vision get weak. So, if there was just a way to rejuvenate those muscles, we would be able to see properly, right? But it is not that simple. Doing so would require surgical options, many of which are not available easily. However, a new study may have made headway into creating an eyedrop that will do the job.
A study presented on Sunday at the European Society of Cataract and Refractive Surgeons (ESCRS) suggests that eye drops could be a safe and effective treatment for presbyopia, a common age-related condition that causes long-sightedness and makes it difficult to focus on close-up objects. The study, conducted by experts in Argentina, explored a new type of eye drop that could offer a convenient alternative to wearing reading glasses.
The eye drops contain two main ingredients that work together to improve near vision. The first is pilocarpine, a drug that makes the pupil smaller and tightens the muscle that controls the shape of the eye's lens. This action helps the eye focus on nearby objects more easily.
The second ingredient is diclofenac, which is a type of anti-inflammatory drug. It helps reduce any inflammation in the eye.
In the study, 766 people used these drops twice a day, typically once in the morning and again about six hours later. They were split into three groups, each receiving a different strength of the pilocarpine component (1%, 2%, or 3%) while the amount of diclofenac stayed the same for everyone.
The study's findings were very encouraging, showing significant improvements in near vision for all participants, with the effects lasting for up to two years.
For the group using the lowest concentration of pilocarpine (1%), almost all 148 people were able to read at least two additional lines on a standard eye chart. In the group with the 2% concentration, 69% of the 248 people could read three or more extra lines. The best results were seen in the 3% group, where a remarkable 84% of the 370 people could read three or more extra lines.
On average, patients saw an improvement of more than three lines on the eye chart just one hour after using the drops. According to Dr. Giovanna Benozzi, a leading researcher, these drops offer a promising solution that is more convenient and has fewer risks than traditional options like reading glasses or surgery.
While the results are positive, some experts have expressed caution about potential side effects. The most common ones reported were temporary blurred vision, eye irritation, and headaches.
However, experts warned that long-term use of pilocarpine could sometimes lead to side effects like reduced night vision. He also noted that using anti-inflammatory drops for a long time could pose risks to the cornea, the clear front part of the eye. He emphasized that more extensive and longer-term studies are needed to confirm the safety and effectiveness of the drops for widespread use.
© 2024 Bennett, Coleman & Company Limited